<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id><journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id><journal-title-group><journal-title>Diagnostic Pathology</journal-title></journal-title-group><issn pub-type="epub">1746-1596</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39732699</article-id><article-id pub-id-type="pmc">PMC11681749</article-id><article-id pub-id-type="publisher-id">1589</article-id><article-id pub-id-type="doi">10.1186/s13000-024-01589-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>(1, 3)-beta-D-Glucan in bronchoalveolar lavage fluid: a useful biomarker in diagnosis of invasive pulmonary infection caused by <italic>Hormographiella aspergillata</italic>?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Haiyan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Jinhui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Junru</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Poon</surname><given-names>Rosana Wing-Shan</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Fanfan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lo</surname><given-names>Simon Kam-Fai</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lau</surname><given-names>Ricky Wing-Tong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Jasper Fuk-Woo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lau</surname><given-names>Susanna Kar-Pui</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chiu</surname><given-names>Kelvin Hei-Yeung</given-names></name><address><email>hychiu09@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/047w7d678</institution-id><institution-id institution-id-type="GRID">grid.440671.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 5373 5131</institution-id><institution>Department of Infectious Disease and Microbiology, </institution><institution>The University of Hong Kong-Shenzhen Hospital, </institution></institution-wrap>Shenzhen, Guangdong China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/047w7d678</institution-id><institution-id institution-id-type="GRID">grid.440671.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 5373 5131</institution-id><institution>Department of Hematology, </institution><institution>The University of Hong Kong-Shenzhen Hospital, </institution></institution-wrap>Shenzhen, Guangdong China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/047w7d678</institution-id><institution-id institution-id-type="GRID">grid.440671.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 5373 5131</institution-id><institution>Department of Pathology, </institution><institution>The University of Hong Kong-Shenzhen Hospital, </institution></institution-wrap>Shenzhen, Guangdong China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02xkx3e48</institution-id><institution-id institution-id-type="GRID">grid.415550.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1764 4144</institution-id><institution>Department of Microbiology, </institution><institution>Queen Mary Hospital, </institution></institution-wrap>Pokfulam, Hong Kong Special Administrative Region China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02zhqgq86</institution-id><institution-id institution-id-type="GRID">grid.194645.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 2757</institution-id><institution>State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, </institution><institution>Carol Yu Centre for Infection, The University of Hong Kong, </institution></institution-wrap>Pokfulam, Hong Kong Special Administrative Region China </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>19</volume><elocation-id>168</elocation-id><history><date date-type="received"><day>27</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1"><italic>Hormographiella aspergillata</italic> is a rare hyaline mold causing invasive fungal infection in humans, until the frequent use of antifungal prophylaxis in immunocompromised hosts. Due to the high mortality of <italic>H. aspergillata</italic> infection, early recognition and treatment are crucial. Previous case reports suggested that serum (1,3)-beta-D-Glucan (BG) is one of the diagnostic aids for <italic>H. aspergillata</italic> infection. Here we report for the first time a case of pulmonary <italic>H. aspergillata</italic> infection with a negative serum BG but positive bronchoalveolar lavage fluid (BAL) BG. This may suggest that BAL BG is a useful and additional microbiological marker for prompt identification of this fatal invasive fungal infection (IFI). But it should be interpreted together with the clinical presentation, imaging, and other laboratory results.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic>Hormographiella aspergillata</italic></kwd><kwd>(1,3)-beta-D-Glucan</kwd><kwd>Invasive fungal infection</kwd><kwd>Amphotericin B</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Invasive fungal infection (IFI) is a serious complication in patients with hematological malignancies. With the use of antifungal prophylaxis in immunocompromised hosts, there is a change in the etiology of fungal infection from <italic>Aspergillus</italic> and <italic>Candida</italic> to more resistant fungi such as <italic>Mucorales</italic>,<italic> Fusarium</italic>,<italic> Scedosporium</italic>, and <italic>Basidiomycetes</italic> [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Pulmonary infection due to <italic>Hormographiella aspergillata</italic> is rare but associated with a high mortality rate, leading to delays in diagnosis and treatment [<xref ref-type="bibr" rid="CR3">3</xref>]. The diagnosis of invasive fungal infection is often difficult, because of risks associated with invasive procedures such as lung biopsy or bronchoalveolar lavage in patients with coagulopathies, low sensitivity of routine fungal culture, together with the long turn-around time in confirmation of fungal identity due to lack of expertise and the need of further tests for confirmation. Previous case reports have reported that serum BG levels were elevated in patients with <italic>H. aspergillata</italic> infection, suggesting it is an important marker of <italic>H. aspergillata</italic> infection [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Here we report the first case of pulmonary <italic>H. aspergillata</italic> infection with a negative serum but a positive BAL BG, suggesting that BAL BG may be a useful and additional tool for prompt diagnosis of this fatal IFI.</p></sec><sec id="Sec2"><title>Presentations</title><p id="Par3">A 34-year-old Chinese female, with newly diagnosed acute lymphoblastic leukemia, was admitted to our hospital for chemotherapy . Prior to admission, she experienced a dry cough and persistent neutropenic fever for 15 days, without improvement despite broad-spectrum antibiotics coverage with biapenem, amikacin, and itraconazole in another hospital. Chemotherapy was administered according to the GRAALL-2003 regimen [<xref ref-type="bibr" rid="CR8">8</xref>] (Intravenous vincristine, daunorubicin, pegaspargase, and cyclophosphamide; oral prednisone; intrathecal methotrexate, cytarabine, and dexamethasone) from day 6 to day 34 of hospitalization. She enjoyed good past health with no known drug allergies. She had no personal history or contact history of pulmonary tuberculosis. She kept no pets at home and had never used any over-the-counter medication or traditional Chinese medicine. She was a non-smoker and a social drinker. Her body temperature was 38.7&#x000a0;&#x000b0;C on admission, with a heart rate of 110 beats per minute, blood pressure of 112/69&#x000a0;mm Hg, respiratory rate of 28 breaths per minute, and oxygen saturation of 80% in room air. There were no palpable lymphadenopathies or finger clubbing. Abdominal, respiratory, and cardiovascular examinations were all unremarkable.</p><p id="Par4">On day 9 of admission, she remained neutropenic and febrile despite broad-spectrum antibiotics (imipenem, vancomycin, trimethoprim-sulfamethoxazole, doxycycline, and levofloxacin) and itraconazole prophylaxis. Computed tomography (CT) of the thorax showed no signs of pneumonia and pulmonary lesions (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). In view of persistent fever, itraconazole was switched to micafungin for antifungal prophylaxis. However, fever still persisted despite adjustment of antifungal, with a repeated CT thorax (day 21) demonstrating two new pulmonary nodules in the right middle lobe with halo signs (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B). Blood culture, sputum for acid-fast bacilli (AFB) smear, and sputum for bacterial culture were unremarkable.&#x000a0;Sputum fungal culture was not ordered and performed. <italic>Mycobacterium tuberculosis</italic> DNA was not detected in the sputum by PCR. Serum galactomannan and BG were negative on Day 22. Bronchoscopy with biopsy was not initially performed due to refusal by the patient and her family, therefore micafungin was empirically switched to caspofungin, with the subsequent addition of voriconazole. However, reassessment CT thorax (day 33) still showed a progression of the right middle lung mass with cavitation (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C). A bronchoscopy with lung biopsy was subsequently performed on the following day (day 34), and a mucous plug containing purulent secretions in the right posterior segmental bronchus was removed and sent for microbiological investigations. Both BAL and lung tissue bacterial cultures were negative, with <italic>Mycobacterium tuberculosis</italic> DNA not detected in the specimens. BAL galactomannan antigen was negative, but BAL BG was positive (&#x0003e;&#x02009;600 pg/mL). Antifungal was subsequently switched to amphotericin B deoxycholate, escalating from 5&#x000a0;mg daily to a treatment dose of 40&#x000a0;mg (1&#x000a0;mg/kg)&#x000a0;daily (from day 34 to day 41) to reduce the chance of acute hypersensitivity reaction. Despite the recovery of her neutrophil level and the administration of amphotericin B deoxycholate, the lung lesions continued to progress (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>D) with her clinical condition deteriorating rapidly, and the patient died from severe hemoptysis and respiratory failure on day 44.</p><p id="Par5">
<fig id="Fig1"><label>Fig. 1</label><caption><p>CT thorax (sagittal view) showing the progression of the lung lesions (arrows). <bold>A</bold>: No signs of pneumonia and pulmonary lesions on day 9; <bold>B</bold>: Two new pulmonary nodules (the biggest one is 1.9&#x02009;&#x000d7;&#x02009;1.5&#x000a0;cm) located in the right middle lobe surrounded by a halo of ground-glass opacity on day 21; <bold>C</bold>: Progression of the right middle lung mass (the biggest one is 3.5&#x02009;&#x000d7;&#x02009;5.2&#x000a0;cm) with cavitation on day 33; <bold>D</bold>: Progression of the right middle lung mass(3.6&#x02009;&#x000d7;&#x02009;5.2&#x000a0;cm) with cavitation on day 41</p></caption><graphic xlink:href="13000_2024_1589_Fig1_HTML" id="d33e361"/></fig>
</p></sec><sec id="Sec3"><title>Mycology and histology</title><p id="Par6">After incubating the BAL and lung tissue on Sabouraud dextrose agar at 37&#x02103; for 48&#x000a0;h, white to cream-colored colonies and cottony aerial mycelium were observed. All inoculated media (Sabouraud dextrose agar, chocolate agar, and blood agar) yielded pure cultures of this fungus in the following days. Staining with lactophenol blue demonstrated septate conidiophores with clusters of smooth-walled, hyaline, and cylindrical arthroconidia (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Pan-fungal PCR and subsequent sequencing using the internal transcribed spacer (ITS) region of the rRNA gene of the isolates were performed. Based on the Basic Local Alignment Search Tool (BLAST) search of the sequence on the ITS region of the isolated fungus, the homology of <italic>Coprinopsis cinerea</italic> culture CBS 338.69 strain (GeneBank Accession No: MH878445.1) was 100.0% (365/ 365&#x000a0;bp), therefore the organism was identified as <italic>Coprinopsis cinerea</italic> (the teleomorph of <italic>Hormographiella aspergillata</italic>). Histology of the lung tissue revealed hyaline, septate, and branched hyphae with evidence of angioinvasion (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Antifungal susceptibility testing was performed by the E-test method on Sabouraud dextrose agar, with the minimal inhibitory concentrations (MIC) of voriconazole and amphotericin B being 32&#x000a0;&#x003bc;g/mL and 0.94&#x000a0;&#x003bc;g/mL, respectively.</p><p id="Par7">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Staining with lactophenol blue demonstrating septate conidiophores with clusters of smooth-walled, hyaline, and cylindrical arthroconidia (10&#x02009;&#x000d7;&#x02009;100)</p></caption><graphic xlink:href="13000_2024_1589_Fig2_HTML" id="d33e390"/></fig>
</p><p id="Par8">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Histology of lung biopsy showing septate (red arrow) and branched hyphae with the formation of clews (white arrow); <bold>A</bold>: Hematoxylin and Eosin stain (magnification,&#x000d7;&#x02009;400); <bold>B</bold>: Gomori-Grocott stain (magnification&#x02009;&#x000d7;&#x02009;400); <bold>C</bold>: Periodic Acid-Schiff stain (magnification&#x02009;&#x000d7;&#x02009;400)</p></caption><graphic xlink:href="13000_2024_1589_Fig3_HTML" id="d33e410"/></fig>
</p></sec><sec id="Sec4" sec-type="discussion"><title>Discussion</title><p id="Par9"><italic>H. aspergillata</italic> belongs to the Basidiomycota division of fungi, and is the asexual form of <italic>Corprinopsis cinerea</italic>, an edible mushroom usually found in compost and other nutrient-rich substrates. <italic>H. aspergillata</italic> is a rare hyaline mold causing invasive fungal infection in humans. Twenty-seven cases were reported in the literature from 23 publications, with infection occurring mainly in patients with hematological malignancies [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. The majority of the patients were diagnosed in Europe, with other cases documented in the United States, Japan, and India. Most cases of <italic>H. aspergillata</italic> infection have been reported as pulmonary and disseminated infections, but the involvement of the skin, central nervous system, eye, and spleen was also reported in immunocompromised patients [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Endocarditis and endophthalmitis have been described in immunocompetent patients [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The mortality rate of <italic>H. aspergillata</italic> infection was high (78%), likely related to the delay in diagnosis and initiation of effective antifungal agents [<xref ref-type="bibr" rid="CR3">3</xref>]. Patients who survived were managed with prompt invasive diagnostic procedures such as bronchoscopy and lung biopsy for respiratory infection, adequate surgical debridement of involved areas, prompt initiation of broad-spectrum antifungal therapy, as well as recovery of neutrophils in patients with underlying hematological malignancies.</p><p id="Par10">Most cases of <italic>H. aspergillata</italic> infection were diagnosed by histology with confirmation by molecular techniques such as PCR and sequencing. Due to the high mortality of <italic>H. aspergillata</italic> infection, early recognition and treatment are crucial. We attempted to evaluate the value of galactomannan, BG, and glucuronoxylomannan (GXM) antigens from previous studies to facilitate the early diagnosis of <italic>H. aspergillata</italic> infection. GXM is the capsular antigen of <italic>Cryptococcus neoformans</italic>, that is widely used for the diagnosis of cryptococcosis. Cross-reactions with GXM have been described in the members of <italic>Basidiomycetes</italic> such as <italic>Trichosporon</italic> and <italic>Coprinopsis cinerea</italic> [<xref ref-type="bibr" rid="CR27">27</xref>]. However, another study has demonstrated that the culture supernatants of <italic>H. aspergillata</italic> produce galactomannan and BG but not GXM [<xref ref-type="bibr" rid="CR4">4</xref>]. This concurs with the two reported cases of <italic>H. aspergillata</italic> infection that the serum GXM antigens were negative [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Despite the in vitro result of positive galactomannan, the diagnostic utility of galactomannan is doubtful, as all documented cases of <italic>H. aspergillata</italic> infection have negative galactomannan assay. The situation of the use of BG for diagnosis is different, with an earlier study showing that BG is an important component of the cell wall of <italic>Coprinus cinereus</italic> [<xref ref-type="bibr" rid="CR28">28</xref>]. In five reported cases of <italic>H. aspergillata</italic> infection with serum BG checked, four (80%) of them had positive serum BG (greater than 500pg/mL) [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Serum BG was also found to be positive seven days prior to the development of radiological changes and at least one month prior to the identification of <italic>H. aspergillata</italic> in one of the case reports [<xref ref-type="bibr" rid="CR7">7</xref>]. In our case, serum BG was negative despite positive radiological findings, but the BAL BG was found to be strongly positive (&#x0003e;&#x02009;600 pg/mL). Although <italic>Candida spp.</italic> colonization or overgrowth at the lower respiratory tract can lead to false positive BAL BG results, yeasts have never been cultured from the respiratory specimens in our case, which further supports <italic>H. aspergillata</italic> as the cause of positive BAL BG in this case. Although BAL BG has a similar sensitivity to BAL galactomannan in the diagnosis of invasive aspergillosis and fungal infection (71%), it exhibits inferior specificity [<xref ref-type="bibr" rid="CR29">29</xref>]. A positive BAL BG should be interpreted together with the clinical presentation, imaging, and other laboratory results for the diagnosis of IFI [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par11">Currently, there is no standardized antifungal susceptibility protocol, clinical breakpoints, and treatment guidelines for <italic>H. aspergillata</italic>. Based on previous in vitro data, Jonathan T et al. summarized the antifungal susceptibility profile of 16 <italic>H. aspergillata</italic> clinical isolates reported in the literature, most cases exhibited a relatively low MIC range of voriconazole (0.015 to 1&#x000a0;mg/L) and amphotericin B (0.03 to 2&#x000a0;mg/L), except one case of amphotericin B MIC was 32&#x000a0;mg/L, while the MIC range of caspofungin (0.5 to 32&#x000a0;mg/L) and micafungin (0.25 to 16&#x000a0;mg/L) were relatively higher, indicating that voriconazole and amphotericin B are important antifungal agents for the treatment of <italic>H. aspergillata</italic> infection [<xref ref-type="bibr" rid="CR3">3</xref>]. Although the method of susceptibility testing used was not standardized, the voriconazole MIC of our <italic>H. aspergillata</italic> isolate was higher than the usual reported range in the literature, which concurs with the fact that our patient did not respond to voriconazole treatment. Breakthrough infection after empirical voriconazole treatment has been reported on three occasions for <italic>H. aspergillata</italic> infection [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Based on the above factors and experience, voriconazole may not be a reliable primary regimen for <italic>H. aspergillata</italic> infection. Amphotericin B should be considered as the first-line antifungal agent.</p><p id="Par12">Voriconazole or liposomal amphotericin B are preferred antifungal agents for the treatment of IFI. Amphotericin B is a polyene antifungal agent with activity in vitro against a wide variety of fungal pathogens [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], including most <italic>Candida</italic> spp, most hyaline and dematiaceous molds, and all dimorphic fungi. Liposomal amphotericin B has been introduced in the market to reduce the toxicities associated with amphotericin B deoxycholate. However, liposomal amphotericin B is not affordable for many patients in developing countries. According to FDA&#x02019;s labeling resources for human prescription drugs, administration of amphotericin B deoxycholate should start with a test dose of 1&#x000a0;mg intravenously over 20 to 30&#x000a0;min, and healthcare workers should observe for any acute hypersensitivity reactions within 30&#x000a0;min. If no reactions were observed, then the remaining treatment dose can be administered. However, the practice in China is different. Amphotericin B deoxycholate is usually administered at a dosage of 1&#x02013;5&#x000a0;mg for the first day, with a stepwise increase by 5&#x000a0;mg daily or alternate day based on the patient&#x02019;s tolerance, until the treatment daily dosage of 0.6-1&#x000a0;mg/kg is reached. Further studies are required to compare the tolerance of patients with the two-dosing approach using the amphotericin B deoxycholate manufactured in China. The stepwise dosing approach delays the achievement of therapeutic concentration, leading to a delay in the management of invasive <italic>H. aspergillata</italic> infection in our patient. Therefore, we believe that in the treatment of severe and life-threatening fungal infection in neutropenic patients, the FDA recommendations of amphotericin B deoxycholate administration should be followed to ensure the timely administration of therapeutic concentrations of antifungal agents.</p></sec><sec id="Sec5" sec-type="conclusion"><title>Conclusion</title><p id="Par13">BAL BG is a useful microbiological investigation for the diagnosis of invasive fungal infection as demonstrated in our case of fatal pulmonary <italic>H. aspergillata</italic> infection, but it should be interpreted with an assessment with clinical presentation, imaging, and other laboratory results. Amphotericin B, instead of voriconazole, should be recommended as the first-line treatment for <italic>H. aspergillata</italic> infection. In the treatment of severe and life-threatening fungal infection in neutropenic patients, the FDA recommendations (test dose then treatment dose) should be followed to ensure the timely administration of therapeutic concentrations of antifungal agents.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>HY, KH-YC and SK-PL contributed to the design of the study. JH, JL, RWP, FX, SK-PL, and RW-TL participated in the acquisition and analysis of data. HY and KH-YC drafted the manuscript, PC and JF-WC revised the manuscript. All of the authors read and approved the final draft of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was partly supported by funding from the Sanming Project of Medicine in Shenzhen, China (SZSM201911014) and the High Level-Hospital Program, Health Commission of Guangdong Province. The funding sources had no role in the study design, data collection, analysis, interpretation, or writing of the report.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval</title><p id="Par171">The study was approved by the Ethics Committee of the University of Hong Kong-Shenzhen Hospital. Written informed consent was obtained from the patient&#x02019;s husband.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par17">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>BAL</term><def><p id="Par18">Bronchoalveolar lavage fluid</p></def></def-item><def-item><term>BG</term><def><p id="Par19">(1,3)-beta-D-Glucan</p></def></def-item><def-item><term>CT</term><def><p id="Par20">Computed tomography</p></def></def-item><def-item><term>GXM</term><def><p id="Par21">Glucuronoxylomannan</p></def></def-item><def-item><term><italic>H. aspergillata</italic></term><def><p id="Par22">
<italic>Hormographiella aspergillata</italic>
</p></def></def-item><def-item><term>IFI</term><def><p id="Par23">Invasive fungal infection</p></def></def-item><def-item><term>ITS</term><def><p id="Par24">Internal transcribed spacer</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Kontoyiannis</surname><given-names>DP</given-names></name><name><surname>Marr</surname><given-names>KA</given-names></name><name><surname>Park</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001&#x02013;2006: overview of the transplant-associated infection surveillance network (TRANSNET) database</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50</volume><issue>8</issue><fpage>1091</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1086/651263</pub-id><pub-id pub-id-type="pmid">20218877</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001&#x02013;2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis. 2010;50(8):1091&#x02013;100.<pub-id pub-id-type="pmid">20218877</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>DL</given-names></name><name><surname>Neofytos</surname><given-names>D</given-names></name><name><surname>Anaissie</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><issue>12</issue><fpage>1695</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1086/599039</pub-id><pub-id pub-id-type="pmid">19441981</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48(12):1695&#x02013;703.<pub-id pub-id-type="pmid">19441981</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Perentes</surname><given-names>JY</given-names></name><name><surname>Beigelman-Aubry</surname><given-names>C</given-names></name><etal/></person-group><article-title>Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature</article-title><source>Med Mycol Case Rep</source><year>2021</year><volume>32</volume><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.mmcr.2021.03.008</pub-id><pub-id pub-id-type="pmid">33996425</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Tschopp J, Perentes JY, Beigelman-Aubry C, et al. Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: report of two cases successfully treated and review of the literature. Med Mycol Case Rep. 2021;32:68&#x02013;72.<pub-id pub-id-type="pmid">33996425</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Moniot</surname><given-names>M</given-names></name><name><surname>Lavergne</surname><given-names>RA</given-names></name><name><surname>Morel</surname><given-names>T</given-names></name><etal/></person-group><article-title>Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review</article-title><source>BMC Infect Dis</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>945</fpage><pub-id pub-id-type="doi">10.1186/s12879-020-05679-z</pub-id><pub-id pub-id-type="pmid">33308180</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Moniot M, Lavergne RA, Morel T, et al. Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review. BMC Infect Dis. 2020;20(1):945.<pub-id pub-id-type="pmid">33308180</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>A</given-names></name><name><surname>Gruenberg</surname><given-names>J</given-names></name><name><surname>Arbefeville</surname><given-names>S</given-names></name><etal/></person-group><article-title>Disseminated Hormographiella aspergillata Infection with Lung and Brain Involvement after Allogenic Hematopoietic Stem-Cell Transplantation in a 54-Year-Old Man</article-title><source>Lab Med</source><year>2019</year><volume>50</volume><issue>4</issue><fpage>426</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/labmed/lmz018</pub-id><pub-id pub-id-type="pmid">31065690</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Chauhan A, Gruenberg J, Arbefeville S, et al. Disseminated Hormographiella aspergillata infection with lung and brain involvement after allogenic hematopoietic stem-cell transplantation in a 54-year-old man. Lab Med. 2019;50(4):426&#x02013;31.<pub-id pub-id-type="pmid">31065690</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Nanno</surname><given-names>S</given-names></name><name><surname>Nakane</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><etal/></person-group><article-title>Disseminated Hormographiella aspergillata infection with involvement of the lung, brain, and small intestine following allogeneic hematopoietic stem cell transplantation: case report and literature review</article-title><source>Transpl Infect Dis</source><year>2016</year><volume>18</volume><issue>4</issue><fpage>611</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/tid.12561</pub-id><pub-id pub-id-type="pmid">27237466</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Nanno S, Nakane T, Okamura H, et al. Disseminated Hormographiella aspergillata infection with involvement of the lung, brain, and small intestine following allogeneic hematopoietic stem cell transplantation: case report and literature review. Transpl Infect Dis. 2016;18(4):611&#x02013;6.<pub-id pub-id-type="pmid">27237466</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Koncan</surname><given-names>R</given-names></name><name><surname>Nadali</surname><given-names>G</given-names></name><name><surname>Favuzzi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Invasive Fungal Infection by Hormographyella aspergillata: A Tricky Diagnosis Triggered by (1,3)-Beta-D-Glucan Assay</article-title><source>J Microb Biochem Technol</source><year>2016</year><volume>8</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.4172/1948-5948.1000309</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Koncan R, Nadali G, Favuzzi V, et al. Invasive fungal infection by Hormographyella aspergillata: a tricky diagnosis triggered by (1,3)-beta-D-Glucan assay. J Microb Biochem Technol. 2016;8:4.</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Huguet</surname><given-names>F</given-names></name><name><surname>Leguay</surname><given-names>T</given-names></name><name><surname>Raffoux</surname><given-names>E</given-names></name><etal/></person-group><article-title>Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study</article-title><source>J Clin Oncol</source><year>2009</year><volume>27</volume><fpage>911</fpage><pub-id pub-id-type="doi">10.1200/JCO.2008.18.6916</pub-id><pub-id pub-id-type="pmid">19124805</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009;27:911.<pub-id pub-id-type="pmid">19124805</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Isabel Cristina</surname><given-names>R</given-names></name><name><surname>Diana</surname><given-names>A</given-names></name><name><surname>Karen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review</article-title><source>Mycopathologia</source><year>2020</year><volume>185</volume><issue>6</issue><fpage>1069</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s11046-020-00488-z</pub-id><pub-id pub-id-type="pmid">32880829</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Isabel Cristina R, Diana A, Karen A, et al. Breakthrough Hormographiella aspergillata infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis: a case report and review. Mycopathologia. 2020;185(6):1069&#x02013;76.<pub-id pub-id-type="pmid">32880829</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Jinagal</surname><given-names>J</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ocular infection caused by Hormographiella aspergillata: A case report and review of literature</article-title><source>J Mycol Med</source><year>2019</year><volume>29</volume><issue>1</issue><fpage>71</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.mycmed.2018.12.002</pub-id><pub-id pub-id-type="pmid">30630667</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Jain N, Jinagal J, Ghosh A, et al. Ocular infection caused by Hormographiella aspergillata: a case report and review of literature. J Mycol Med. 2019;29(1):71&#x02013;4.<pub-id pub-id-type="pmid">30630667</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Godet</surname><given-names>C</given-names></name><name><surname>Cateau</surname><given-names>E</given-names></name><name><surname>Rammaert</surname><given-names>B</given-names></name><etal/></person-group><article-title>Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review</article-title><source>Mycopathologia</source><year>2017</year><volume>182</volume><issue>7&#x02013;8</issue><fpage>709</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1007/s11046-017-0117-9</pub-id><pub-id pub-id-type="pmid">28144821</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Godet C, Cateau E, Rammaert B, et al. Nebulized liposomal amphotericin B for treatment of pulmonary infection caused by hormographiella aspergillata: case report and literature review. Mycopathologia. 2017;182(7&#x02013;8):709&#x02013;13.<pub-id pub-id-type="pmid">28144821</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Correa-Martinez</surname><given-names>C</given-names></name><name><surname>Brentrup</surname><given-names>A</given-names></name><name><surname>Hess</surname><given-names>K</given-names></name><etal/></person-group><article-title>First description of a local Coprinopsis cinerea skin and soft tissue infection</article-title><source>New Microbes New Infect</source><year>2017</year><volume>21</volume><fpage>102</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.nmni.2017.11.008</pub-id><pub-id pub-id-type="pmid">29541477</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Correa-Martinez C, Brentrup A, Hess K, et al. First description of a local Coprinopsis cinerea skin and soft tissue infection. New Microbes New Infect. 2017;21:102&#x02013;4.<pub-id pub-id-type="pmid">29541477</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Heiblig</surname><given-names>M</given-names></name><name><surname>Bozzoli</surname><given-names>V</given-names></name><name><surname>Saison</surname><given-names>J</given-names></name><etal/></person-group><article-title>Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient</article-title><source>Mycoses</source><year>2015</year><volume>58</volume><issue>5</issue><fpage>308</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/myc.12305</pub-id><pub-id pub-id-type="pmid">25752189</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Heiblig M, Bozzoli V, Saison J, et al. Combined medico-surgical strategy for invasive sino-orbito-cerebral breakthrough fungal infection with Hormographiella aspergillata in an acute leukaemia patient. Mycoses. 2015;58(5):308&#x02013;12.<pub-id pub-id-type="pmid">25752189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Corzo-Leon</surname><given-names>DE</given-names></name><name><surname>Satlin</surname><given-names>MJ</given-names></name><name><surname>Soave</surname><given-names>R</given-names></name><etal/></person-group><article-title>Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens</article-title><source>Mycoses</source><year>2015</year><volume>58</volume><issue>6</issue><fpage>325</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1111/myc.12318</pub-id><pub-id pub-id-type="pmid">25808822</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Corzo-Leon DE, Satlin MJ, Soave R, et al. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses. 2015;58(6):325&#x02013;36.<pub-id pub-id-type="pmid">25808822</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Bojic</surname><given-names>M</given-names></name><name><surname>Willinger</surname><given-names>B</given-names></name><name><surname>Rath</surname><given-names>T</given-names></name><etal/></person-group><article-title>Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview</article-title><source>Mycoses</source><year>2013</year><volume>56</volume><issue>6</issue><fpage>687</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/myc.12087</pub-id><pub-id pub-id-type="pmid">23672484</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Bojic M, Willinger B, Rath T, et al. Fatal skin and pulmonary infection caused by Hormographiella aspergillata in a leukaemic patient: case report and literature overview. Mycoses. 2013;56(6):687&#x02013;9.<pub-id pub-id-type="pmid">23672484</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>KP</given-names></name><name><surname>Godet</surname><given-names>C</given-names></name><name><surname>Fekkar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Breakthrough invasive mould infections in patients treated with caspofungin</article-title><source>J Infect</source><year>2012</year><volume>64</volume><issue>4</issue><fpage>424</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2011.12.015</pub-id><pub-id pub-id-type="pmid">22227384</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Pang KP, Godet C, Fekkar A, et al. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect. 2012;64(4):424&#x02013;9.<pub-id pub-id-type="pmid">22227384</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Conen</surname><given-names>A</given-names></name><name><surname>Weisser</surname><given-names>M</given-names></name><name><surname>Hohler</surname><given-names>D</given-names></name><etal/></person-group><article-title>Hormographiella aspergillata: an emerging mould in acute leukaemia patients?</article-title><source>Clin Microbiol Infect</source><year>2011</year><volume>17</volume><issue>2</issue><fpage>273</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03266.x</pub-id><pub-id pub-id-type="pmid">20491830</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Conen A, Weisser M, Hohler D, et al. Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clin Microbiol Infect. 2011;17(2):273&#x02013;7.<pub-id pub-id-type="pmid">20491830</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez</surname><given-names>F</given-names></name><name><surname>Olivier</surname><given-names>G</given-names></name><name><surname>Garcia-Hermoso</surname><given-names>D</given-names></name><name><surname>Randriamalala</surname><given-names>E</given-names></name><etal/></person-group><article-title>Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin</article-title><source>J Clin Microbiol</source><year>2011</year><volume>49</volume><issue>1</issue><fpage>461</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1128/JCM.01213-10</pub-id><pub-id pub-id-type="pmid">21068290</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Suarez F, Olivier G, Garcia-Hermoso D, Randriamalala E, et al. Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin. J Clin Microbiol. 2011;49(1):461&#x02013;5.<pub-id pub-id-type="pmid">21068290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Abuali</surname><given-names>MM</given-names></name><name><surname>Posada</surname><given-names>R</given-names></name><name><surname>Toro</surname><given-names>GD</given-names></name><etal/></person-group><article-title>Rhizomucor variabilis var.regularior and Hormographiella aspergillata Infections in a Leukemic Bone Marrow Transplant Recipient with Refractory Neutropenia</article-title><source>J Clin Microbiol</source><year>2009</year><volume>47</volume><issue>12</issue><fpage>4176</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1128/JCM.00305-09</pub-id><pub-id pub-id-type="pmid">19846651</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Abuali MM, Posada R, Toro GD, et al. Rhizomucor variabilis var.regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol. 2009;47(12):4176&#x02013;9.<pub-id pub-id-type="pmid">19846651</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Greer EL, Kowalski TJ, Cole ML et al. Truffles revenge a pig-eating fungus. Cardiol Path. 2008;17(5):342-3.</mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagrou</surname><given-names>K</given-names></name><name><surname>Massonet</surname><given-names>C</given-names></name><name><surname>Theunissen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata</article-title><source>J Med Microbiol</source><year>2005</year><volume>54</volume><issue>7</issue><fpage>685</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.46016-0</pub-id><pub-id pub-id-type="pmid">15947435</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lagrou K, Massonet C, Theunissen K, et al. Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol. 2005;54(7):685&#x02013;8.<pub-id pub-id-type="pmid">15947435</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Surmont</surname><given-names>I</given-names></name><name><surname>Aelst</surname><given-names>FV</given-names></name><name><surname>Verbanck</surname><given-names>J</given-names></name><etal/></person-group><article-title>A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode</article-title><source>Med Mycol</source><year>2002</year><volume>40</volume><issue>2</issue><fpage>217</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/mmy.40.2.217.219</pub-id><pub-id pub-id-type="pmid">12058736</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Surmont I, Aelst FV, Verbanck J, et al. A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. Med Mycol. 2002;40(2):217&#x02013;9.<pub-id pub-id-type="pmid">12058736</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Verweij</surname><given-names>PE</given-names></name><name><surname>Kasteren</surname><given-names>MV</given-names></name><name><surname>Nes</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata</article-title><source>J Clin Microbiol</source><year>1997</year><volume>35</volume><issue>10</issue><fpage>2675</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/jcm.35.10.2675-2678.1997</pub-id><pub-id pub-id-type="pmid">9316933</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Verweij PE, Kasteren MV, Nes J, et al. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J Clin Microbiol. 1997;35(10):2675&#x02013;8.<pub-id pub-id-type="pmid">9316933</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Nenoff</surname><given-names>P</given-names></name><name><surname>Friedrich</surname><given-names>T</given-names></name><name><surname>Schwerke</surname><given-names>H</given-names></name><etal/></person-group><article-title>Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient</article-title><source>J Med Vet Mycol</source><year>1997</year><volume>35</volume><issue>1</issue><fpage>65</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/02681219780000901</pub-id><pub-id pub-id-type="pmid">9061589</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Nenoff P, Friedrich T, Schwerke H, et al. Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. J Med Vet Mycol. 1997;35(1):65&#x02013;9.<pub-id pub-id-type="pmid">9061589</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Bartz-Schmidt</surname><given-names>KU</given-names></name><name><surname>Tintelnot</surname><given-names>K</given-names></name><name><surname>Steffen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>1996</year><volume>234</volume><issue>9</issue><fpage>591</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1007/BF00448805</pub-id><pub-id pub-id-type="pmid">8880159</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Bartz-Schmidt KU, Tintelnot K, Steffen M, et al. Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Graefes Arch Clin Exp Ophthalmol. 1996;234(9):591&#x02013;3.<pub-id pub-id-type="pmid">8880159</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Speller</surname><given-names>DE</given-names></name><name><surname>Maclver</surname><given-names>AG</given-names></name></person-group><article-title>Endocarditis caused by a coprinus species a fungus of the toadstool group</article-title><source>J Med Microbiol</source><year>1970</year><volume>4</volume><issue>3</issue><fpage>370</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1099/00222615-4-3-370</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Speller DE, Maclver AG. Endocarditis caused by a coprinus species a fungus of the toadstool group. J Med Microbiol. 1970;4(3):370&#x02013;4.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Tone K, Umeda Y, Makimura K. Cross-reactivity in cryptococcus antigen latex agglutination test in two commercial kits. Med Mycol. 2016;54(4):439&#x02013;43.</mixed-citation></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Sietsma</surname><given-names>JH</given-names></name><name><surname>Wessels</surname><given-names>JG</given-names></name></person-group><article-title>Solubility of (1 leads to 3)-beta-D/(1leads to 6)-beta-D-glucan in fungal walls: importance of presumed linkage between glucan and chitin</article-title><source>J Gen Microbiol</source><year>1981</year><volume>125</volume><issue>1</issue><fpage>209</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">6460846</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Sietsma JH, Wessels JG. Solubility of (1 leads to 3)-beta-D/(1leads to 6)-beta-D-glucan in fungal walls: importance of presumed linkage between glucan and chitin. J Gen Microbiol. 1981;125(1):209&#x02013;12.<pub-id pub-id-type="pmid">6460846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Reischies</surname><given-names>FMJ</given-names></name><name><surname>Prattes</surname><given-names>J</given-names></name><name><surname>Pruller</surname><given-names>F</given-names></name><etal/></person-group><article-title>Prognostic potential of 1,3-beta-d-glucan levels in bronchoalveolar lavage fluid samples</article-title><source>J Infect</source><year>2016</year><volume>72</volume><issue>1</issue><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2015.09.016</pub-id><pub-id pub-id-type="pmid">26416472</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Reischies FMJ, Prattes J, Pruller F, et al. Prognostic potential of 1,3-beta-d-glucan levels in bronchoalveolar lavage fluid samples. J Infect. 2016;72(1):29&#x02013;35.<pub-id pub-id-type="pmid">26416472</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>XM</given-names></name><etal/></person-group><article-title>Diagnostic value of (1 &#x02192; 3)-&#x003b2;-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis</article-title><source>Respir Med</source><year>2016</year><volume>117</volume><fpage>48</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2016.05.017</pub-id><pub-id pub-id-type="pmid">27492513</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Shi X, Liu Y, Gu XM, et al. Diagnostic value of (1 &#x02192; 3)-&#x003b2;-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: a meta-analysis. Respir Med. 2016;117:48&#x02013;53.<pub-id pub-id-type="pmid">27492513</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>